Morphett joined Avondale in 2004 as head of healthcare investment banking, where he helped establish the firm as a nationally-recognized provider of advisory and capital raising services for public and private companies. Since his arrival, the firm has closed $15bn of assignments for healthcare firms throughout the country.
Prior to coming to Avondale, Morphett founded Australian corporate finance advisory firm Rosebrook Ventures. He is a former investment banking Managing Director at Morgan Stanley where he served in various positions for 14 years, primarily in New York and Sydney, Australia.
Pat Shepherd, chief executive officer for Avondale Partners, announced Morphett's new position, praising him for his experience and approach. 'Jonathan is one of the brightest minds in investment banking and one of the most enjoyable people to work with. He has built our healthcare group into one of the strongest boutiques in the country, becoming a respected voice in that industry and an insightful advisor to our clients. These strengths have already produced strong growth for our investment banking group, and we expect that to continue under Jonathan's leadership'.
Morphett expressed enthusiasm for the opportunity, saying, 'The investment bankers at Avondale are outstanding individuals and exceptional advisors. That combination is one of the reasons that Avondale has become a trusted resource for our clients. I am honored to be able to lead this group'.
Morphett is a former board member of the Nashville Health Care Council and was recognized as a 2012 Health Care Hero award winner by the Nashville Business Journal. He currently serves as a member of the Board of Directors for Friend's Life, a non-profit organization dedicated to improving the lives of people with disabilities. He received his Bachelor of Laws and Bachelor of Economics degrees from the University of Adelaide, Australia, in 1981 and his MBA degree from the Tuck School at Dartmouth College in 1986.